Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Entacapone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 225Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rising's Generic Carbidopa, Levodopa & Entacapone Receives Approval in the U.S.
    Rising's Generic Carbidopa, Levodopa & Entacapone Receives Approval in the U.S.

    25 Jan 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213212

    FDA
    25 Jan 2022
    Share Share
    Alembic Pharm's Generic Entacapone Receives Approval in the U.S.
    Alembic Pharm's Generic Entacapone Receives Approval in the U.S.

    04 Jan 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212601

    FDA
    04 Jan 2022
    Share Share
    Neurocrine Biosciences Presents Data Demonstrating Efficacy of Approved ONGENTYS
    Neurocrine Biosciences Presents Data Demonstrating Efficacy of Approved ONGENTYS

    11 Sep 2020

    // PRNNEWSWIRE

    https://www.prnewswire.com/news-releases/neurocrine-biosciences-presents-new-data-analyses-demonstrating-efficacy-of-fda-approved-once-daily-ongentys-opicapone-in-patients-with-parkinsons-disease-at-the-mds-virtual-congress-2020-301128393.html

    PRNNEWSWIRE
    11 Sep 2020
    Share Share
    Mylan Pharms`s Carbidopa;Entacapone;LevodopaTentative Approval in US
    Mylan Pharms`s Carbidopa;Entacapone;LevodopaTentative Approval in US

    19 Aug 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203424

    FDA
    19 Aug 2020
    Share Share
    Lobsor Pharma receives Japanese patent for APD solution
    Lobsor Pharma receives Japanese patent for APD solution

    30 Oct 2019

    // BIOSPECTRUMASIA

    https://www.biospectrumasia.com/news/25/14786/lobsor-pharma-receives-japanese-patent-for-apd-solution.html

    BIOSPECTRUMASIA
    30 Oct 2019
    Share Share
    FDA review finds no increased risk of prostate cancer Comtan, Stalevo
    FDA review finds no increased risk of prostate cancer Comtan, Stalevo

    13 Aug 2019

    // FDA

    https://www.fda.gov/drugs/drug-safety-and-availability/fda-review-finds-no-increased-risk-prostate-cancer-parkinsons-disease-medicines-containing

    FDA
    13 Aug 2019
    Share Share